Related Experiment Videos
Intentional overdose and death with 3,4-methylenedioxyethamphetamine (MDEA; "Eve"): case report
Abstract:
We report a case of suicide following ingestion of a large dose of 3,4-methylenedioxyethamphetamine (MDEA, "Eve") in a 27-year-old woman with a history of depression. Several days before her death, she had attempted suicide with benzodiazepines resulting in a 24-hour hospital admission; at that time, no physiologic abnormalities were detected. Findings on autopsy were nonspecific. Toxicologic analysis showed a high concentration of MDEA and the appearance of benzodiazepines in body fluids. Ethanol and other drugs of abuse were not found. We discuss the clinical manifestations, toxicologic syndromes, and mechanisms of death with amphetamine intoxication. MDEA intoxication in young people may result in sudden death.
Insights
A woman died by suicide after taking a large dose of 3,4-methylenedioxyethamphetamine (MDEA). This case highlights the potential for MDEA intoxication to cause sudden death in young individuals.
Area of Science:
- Forensic Toxicology
- Psychopharmacology
- Clinical Toxicology
Background:
- 3,4-methylenedioxyethamphetamine (MDEA) is a psychoactive drug with potential for abuse.
- Previous suicide attempt with benzodiazepines noted in patient history.
- Understanding MDEA's role in fatal outcomes is crucial.
Observation:
- A 27-year-old female with a history of depression died by suicide.
- Toxicology confirmed high MDEA concentration and presence of benzodiazepines.
- Autopsy revealed nonspecific findings.
Findings:
- High MDEA levels detected in biological samples.
- Co-ingestion of benzodiazepines identified.
- Absence of ethanol and other drugs of abuse confirmed.
Implications:
- MDEA overdose can lead to fatal outcomes, including sudden death.
- Clinical manifestations and toxicologic syndromes of amphetamine intoxication warrant further study.
- This case underscores the risks associated with MDEA use in vulnerable populations.